The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.
First quarter repayment £138m higher than this time last year
drugs such as its next-generation breast cancer drug Perjeta (pertuzumab). ... This was highlighted in England where last year the country's health technology assessor NICE said Perjeta was nearly double the price (at £90, 000) than it would consider
Sales of the company's HER2-targeting drugs - Herceptin (trastuzumab) and follow-up therapies Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine) - grew 23% thanks to increased use of Herceptin and Perjeta in ... The growth of Perjeta - up 82% to
The Swiss firm has, in relative terms at least, not come out too badly during the de-listing process as two of its newer cancer medicines, namely breast cancer treatments Perjeta
Perjeta and Kadcyla boost 2014 revenues. Solid growth for Roche's breast cancer blockbuster Herceptin was backed up by big gains for two follow-up products in the last quarter for ... Roche's breast cancer franchise was particularly boosted by the
[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...